Securities

Helius Medical Technologies has priced its public offering, offering 2,768,600 shares of Class A common stock equivalents with warrants for an additional 2,768,600 shares at $3.27 per unit. Warrants have a 2.5-year lifespan and an initial exercise price of $7.35. The offering is expected to close June 6, 2025, with gross proceeds of $9.1 million. Maxim Group LLC is the placement agent.

Fannie Mae announced the results of its tender offers for specific Connecticut Avenue Securities notes. The offers, outlined on May 22, 2025, targeted various note classes and reflect Fannie Mae’s strategy to manage risk and adjust its portfolio for market stability. Approximately $1.798 billion in principal amount of notes were tendered by the May 29, 2025 deadline. The announcement provides detailed data on the securities, including CUSIP, ISIN, and tender percentages.